3 Year Absolute Returns
90.43% ↑
NAV (₹) on 16 Jul 2026
50.05
1 Day NAV Change
0.79%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment ... Read more
AUM
₹ 3,514.02 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 61.79% |
| Foreign Securities | 16.25% |
| Hospitals & Medical Services | 12.88% |
| Treps/Reverse Repo | 7.64% |
| Finance - Non Life Insurance | 1.20% |
| International Mutual Fund Units | 0.94% |
| Medical Equipment & Accessories | 0.18% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Cipla Limited | 8.35% | ₹ 293.28 | Pharmaceuticals |
| IPCA Laboratories Limited | 8.21% | ₹ 288.55 | Pharmaceuticals |
| Sun Pharmaceutical Industries Limited | 8.14% | ₹ 286 | Pharmaceuticals |
| TREPS / Reverse Repo Investments | 7.64% | ₹ 268.43 | Others |
| Illumina Inc | 7.59% | ₹ 266.79 | Others |
| Sai Life Sciences Limited | 6.88% | ₹ 241.60 | Pharmaceuticals |
| Gland Pharma Limited | 6.54% | ₹ 229.71 | Pharmaceuticals |
| Globus Medical Inc | 5.72% | ₹ 200.91 | Others |
| Apollo Hospitals Enterprise Limited | 4.81% | ₹ 169.10 | Hospitals & Medical Services |
| Cohance Lifesciences Limited | 4.13% | ₹ 145.05 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 3.60% | ₹ 126.54 | Hospitals & Medical Services |
| Alembic Pharmaceuticals Limited | 3.38% | ₹ 118.68 | Pharmaceuticals |
| Kovai Medical Center and Hospital Limited | 2.87% | ₹ 100.78 | Hospitals & Medical Services |
| Procter & Gamble Health Limited | 2.87% | ₹ 100.77 | Pharmaceuticals |
| Alkem Laboratories Limited | 2.61% | ₹ 91.79 | Pharmaceuticals |
| Pfizer Limited | 2.53% | ₹ 89.07 | Pharmaceuticals |
| Indoco Remedies Limited | 2.21% | ₹ 77.64 | Pharmaceuticals |
| Intuitive Surgical Inc | 2.01% | ₹ 70.60 | Others |
| Concord Biotech Limited | 1.81% | ₹ 63.59 | Pharmaceuticals |
| Unichem Laboratories Limited | 1.46% | ₹ 51.28 | Pharmaceuticals |
| Syngene International Limited | 1.38% | ₹ 48.66 | Pharmaceuticals |
| Nephrocare Health Services Limited | 1.22% | ₹ 43.01 | Hospitals & Medical Services |
| ICICI Lombard General Insurance Company Limited | 1.20% | ₹ 42.05 | Finance - Non Life Insurance |
| Global X Funds - Global X Genomics & Biotechnology ETF | 0.94% | ₹ 32.93 | Others |
| Aarti Drugs Limited | 0.92% | ₹ 32.20 | Pharmaceuticals |
| Abbott Laboratories | 0.77% | ₹ 27.12 | Others |
| Jupiter Life Line Hospitals Limited | 0.38% | ₹ 13.37 | Hospitals & Medical Services |
| Emcure Pharmaceuticals Limited | 0.37% | ₹ 12.85 | Pharmaceuticals |
| Laxmi Dental Limited | 0.18% | ₹ 6.31 | Medical Equipment & Accessories |
| Grail Inc | 0.16% | ₹ 5.64 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 15.44% | 12.76% | 13.50% | 23.95% |
| Category returns | 3.38% | 4.52% | 6.23% | 22.69% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹28.93 | 16.75% | 171.42% | 0.00% | ₹10,529 | 1.80% |
Very High
|
What is the current NAV of DSP Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of DSP Healthcare Fund - Direct Plan Growth?
What are the historical returns of DSP Healthcare Fund - Direct Plan Growth?
What is the risk level of DSP Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for DSP Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article